Trial · NCT02484703
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants With Adverse Events (AEs) | Baseline up to Week 6 | |
| Primary | Percentage of Participants With Epileptiform Abnormalities as Assessed Using Electroencephalogram (EEG) Analysis | Baseline up to Week 6 | |
| Primary | Percentage of Participants by Suicidality Classification as Assessed Using an Adapted Form of the Columbia Classification Algorithm for Suicide Assessment (C-CASA) | Baseline up to Week 6 | |
| Primary | Anxiety, Depression, and Mood Scale (ADAMS) Score | Baseline up to Week 6 | |
| Primary | Hyperactivity and Impulsivity as Assessed by the Short Version of Conners Third Edition Parent Short-Form (Conners-3) Score | Baseline up to Week 6 | |
| Primary | Sleep Disturbances as Assessed by the Children's Sleep Habits Questionnaire (CSHQ) Score | Baseline up to Week 6 | |
| Primary | Gamma Power at Posterior Electrodes as Assessed Using EEG Analysis | Baseline up to Week 6 | |
| Primary | Theta Power at Posterior Electrodes as Assessed Using EEG Analysis | Baseline up to Week 6 | |
| Primary | Cognition as Assessed by the Children's Memory Scale (CMS) Subtests Score | Baseline up to Week 6 | |
| Secondary | Percentage of Participants With AEs | Baseline up to Week 26 | |
| Secondary | Percentage of Participants With Epileptiform Abnormalities as Assessed Using EEG Analysis | Baseline up to Week 26 | |
| Secondary | Percentage of Participants by Suicidality Classification as Assessed Using an Adapted Form of the C-CASA | Baseline up to Week 26 | |
| Secondary | ADAMS Score | Baseline up to Week 26 | |
| Secondary | Hyperactivity and Impulsivity as Assessed by the Short Version of Conners-3 Score | Baseline up to Week 26 | |
| Secondary | Sleep Disturbances as Assessed by the CSHQ Score | Baseline up to Week 26 | |
| Secondary | Gamma Power at Posterior Electrodes as Assessed Using EEG Analysis | Baseline up to Week 26 | |
| Secondary | Theta Power at Posterior Electrodes as Assessed Using EEG Analysis | Baseline up to Week 26 | |
| Secondary | Cognition as Assessed by the CMS Subtests Score | Baseline up to Week 26 | |
| Secondary | Adaptive Behavior as Assessed by the Vineland Adaptive Behavior Scales-II (VABS-II) Score | Baseline up to Week 26 | |
| Secondary | Clinical Global Impression-Improvement (CGI-I) Scale Score | Baseline up to Week 26 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02484703/registered